Dr. Reddys Duvvada Facility Cited by FDA Again
[ Price : $8.95]
FDA issues a 13-item FDA-483 to Dr. Reddys oncology drug manufacturing facility at Duvvada, Visakhapatnam, India.
FDA Releases Dr. Reddys Warning Letter
[ Price : $8.95]
FDA releases its 11/5 Warning Letter to Dr. Reddys Laboratories detailing findings from inspections at three of the companys facil...
Hutt Discusses Turning Points in FDAs History
[ Price : $8.95]
Former FDA chief counsel Peter Barton Hutt delivers an outline of major turning points in FDAs history, touching on FDA enforcemen...
